The pricing agreement between Novo Nordisk and Eli Lilly and the Trump administration on GLP-1 drugs for diabetes and obesity has arrived.

Since President Donald Trump began his emphatic push to reduce drug prices, a looming question has been how low he could bring down the price

Novo Nordisk has once again upped its bid for Metsera, according to sources familiar with the matter, in an effort to beat out a raised

Vera Therapeutics built its case for a rare kidney disease drug Thursday morning, revealing a fuller Phase 3 dataset after toplining the results earlier this

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. UPS has acquired US-based supply chain